JP2010514842A5 - - Google Patents

Download PDF

Info

Publication number
JP2010514842A5
JP2010514842A5 JP2009544958A JP2009544958A JP2010514842A5 JP 2010514842 A5 JP2010514842 A5 JP 2010514842A5 JP 2009544958 A JP2009544958 A JP 2009544958A JP 2009544958 A JP2009544958 A JP 2009544958A JP 2010514842 A5 JP2010514842 A5 JP 2010514842A5
Authority
JP
Japan
Prior art keywords
benzamide
benzyl
tetrahydro
dimethoxy
ylcarbamoyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2009544958A
Other languages
English (en)
Japanese (ja)
Other versions
JP5258790B2 (ja
JP2010514842A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2008/050014 external-priority patent/WO2008086047A1/en
Publication of JP2010514842A publication Critical patent/JP2010514842A/ja
Publication of JP2010514842A5 publication Critical patent/JP2010514842A5/ja
Application granted granted Critical
Publication of JP5258790B2 publication Critical patent/JP5258790B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2009544958A 2007-01-03 2008-01-02 Rhoキナーゼインヒビター Expired - Fee Related JP5258790B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US87862507P 2007-01-03 2007-01-03
US60/878,625 2007-01-03
PCT/US2008/050014 WO2008086047A1 (en) 2007-01-03 2008-01-02 Rho kinase inhibitors

Publications (3)

Publication Number Publication Date
JP2010514842A JP2010514842A (ja) 2010-05-06
JP2010514842A5 true JP2010514842A5 (enExample) 2011-02-24
JP5258790B2 JP5258790B2 (ja) 2013-08-07

Family

ID=39313484

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2009544958A Expired - Fee Related JP5258790B2 (ja) 2007-01-03 2008-01-02 Rhoキナーゼインヒビター

Country Status (8)

Country Link
US (1) US8093266B2 (enExample)
EP (1) EP2114869B1 (enExample)
JP (1) JP5258790B2 (enExample)
AR (1) AR064726A1 (enExample)
CA (1) CA2674389A1 (enExample)
CL (1) CL2007003874A1 (enExample)
TW (1) TW200843770A (enExample)
WO (1) WO2008086047A1 (enExample)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0721333D0 (en) * 2007-10-31 2007-12-12 Motac Neuroscience Ltd Medicaments
US20110230472A1 (en) * 2008-08-29 2011-09-22 Shionogi & Co., Ltd. Ring-fused azole derivative having pi3k-inhibiting activity
AU2010276215A1 (en) * 2009-07-21 2012-02-16 Auckland Uniservices Limited Heteroaryl benzamides, compositions and methods of use
US9126978B2 (en) 2009-11-17 2015-09-08 The Regents Of The University Of Michigan 1,4-benzodiazepine-2,5-diones and related compounds with therapeutic properties
EP2531490B1 (en) * 2010-02-02 2014-10-15 Novartis AG Cyclohexyl amide derivatives as crf receptor antagonists
US8697911B2 (en) 2010-07-07 2014-04-15 Boehringer Ingelheim International Gmbh Rho kinase inhibitors
US9079880B2 (en) * 2010-07-07 2015-07-14 Boehringer Ingelheim International Gmbh Rho kinase inhibitors
US9000154B2 (en) 2010-10-19 2015-04-07 Boehringer Ingelheim International Gmbh Rho kinase inhibitors
SG10202010119TA (en) * 2010-11-15 2020-11-27 Abbvie Inc NAMPT And Rock Inhibitors
US9029370B2 (en) * 2011-06-10 2015-05-12 Hoffmann-La Roche Inc. Substituted benzamide derivatives
US8921576B2 (en) 2011-10-19 2014-12-30 Kowa Company, Ltd. Spiroindoline compound, and medicinal agent comprising same
JP6062958B2 (ja) 2011-12-20 2017-01-18 バイエル・インテレクチュアル・プロパティ・ゲゼルシャフト・ミット・ベシュレンクテル・ハフツングBayer Intellectual Property GmbH 新規殺虫性芳香族アミド類
CA2885217C (en) 2012-09-20 2019-10-08 Temple University - Of The Commonwealth System Of Higher Education Substituted alkyl diaryl derivatives, methods of preparation and uses
ES2684776T3 (es) 2013-01-18 2018-10-04 Bristol-Myers Squibb Company Ftalazinonas e isoquinolinonas como inhibidores de ROCK
WO2014177699A1 (en) * 2013-05-03 2014-11-06 INSERM (Institut National de la Santé et de la Recherche Médicale) Rhoa (rock) inhibitors for the treatment of enflammatory bowel disease
US9902702B2 (en) 2014-07-15 2018-02-27 Bristol-Myers Squibb Company Spirocycloheptanes as inhibitors of rock
CN107108581B (zh) 2014-08-21 2020-06-23 百时美施贵宝公司 作为强效rock抑制剂的回接苯甲酰胺衍生物
EP3294871B1 (en) 2015-05-12 2026-04-29 HemostOD SA Combination of pharmacological and microfluidic features for improved platelets production
CN107709314A (zh) 2015-06-11 2018-02-16 巴斯利尔药物国际股份公司 外排泵抑制剂及其治疗性用途
CN105195114B (zh) * 2015-10-29 2017-08-25 重庆郑博生物科技有限公司 脓毒症多种致病因子的吸附材料及其制备方法和用途
TWI730032B (zh) 2016-01-13 2021-06-11 美商必治妥美雅史谷比公司 作為rock抑制劑之螺庚烷水楊酸醯胺及相關化合物
JP7155102B2 (ja) 2016-07-07 2022-10-18 ブリストル-マイヤーズ スクイブ カンパニー Rock阻害剤としてのスピロ縮合環尿素
WO2018108156A1 (zh) * 2016-12-16 2018-06-21 成都先导药物开发有限公司 Rock抑制剂及其应用
CN110914257B (zh) 2017-07-12 2023-05-26 百时美施贵宝公司 作为rock抑制剂的螺庚基乙内酰脲
JP7234201B2 (ja) 2017-07-12 2023-03-07 ブリストル-マイヤーズ スクイブ カンパニー 心不全の治療のためのrockの5員アミノヘテロ環および5,6-または6,6員二環式アミノヘテロ環の阻害剤
TW201908293A (zh) 2017-07-12 2019-03-01 美商必治妥美雅史谷比公司 作為rock抑制劑之5員及雙環雜環醯胺
WO2019014300A1 (en) 2017-07-12 2019-01-17 Bristol-Myers Squibb Company PHENYLACETAMIDES AS ROCK INHIBITORS
CA3110661A1 (en) 2018-08-29 2020-03-05 University Of Massachusetts Inhibition of protein kinases to treat friedreich ataxia
US20250074904A1 (en) * 2021-11-17 2025-03-06 The University Of North Carolina At Chapel Hill Nsd2-targeted checmical degraderts and compositions and methods of use thereof
WO2024076155A1 (ko) * 2022-10-04 2024-04-11 노보렉스 주식회사 Yeats 도메인 억제제로서 신규한 화합물
WO2025240834A1 (en) * 2024-05-17 2025-11-20 The University Of North Carolina At Chapel Hill Nsd2-targeted chemical degraders and compositions and methods of use thereof

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ332341A (en) * 1996-05-20 2000-05-26 Darwin Discovery Ltd Quinoline carboxamides as TNF inhibitors and as PDE-IV inhibitors
JPH11139969A (ja) * 1997-08-07 1999-05-25 Tanabe Seiyaku Co Ltd 医薬組成物
JPH11130751A (ja) 1997-10-30 1999-05-18 Yoshitomi Pharmaceut Ind Ltd アミド化合物およびそれらの酸付加塩の標識化合物
US7217722B2 (en) * 2000-02-01 2007-05-15 Kirin Beer Kabushiki Kaisha Nitrogen-containing compounds having kinase inhibitory activity and drugs containing the same
EP1403255A4 (en) 2001-06-12 2005-04-06 Sumitomo Pharma RHO KINASE INHIBITORS
DE10357510A1 (de) * 2003-12-09 2005-07-07 Bayer Healthcare Ag Heteroarylsubstituierte Benzole
JP2007519754A (ja) * 2004-01-30 2007-07-19 スミスクライン ビーチャム コーポレーション 化合物

Similar Documents

Publication Publication Date Title
US7868001B2 (en) Cytokine inhibitors
JP5258790B2 (ja) Rhoキナーゼインヒビター
JP6511430B2 (ja) がんの治療のための化合物および組成物
AU2002226674B2 (en) Tricyclic and heterocyclic derivative compounds and drugs containing these compounds as the active ingredient
JP2012502986A5 (enExample)
KR20090127307A (ko) 히스타민 h3 수용체 조절제로서의 테트라하이드로이소퀴놀린 화합물
RU2019136536A (ru) Ингибиторы гистондеацетилаз (hdac)
RU2681849C2 (ru) Гетероциклические производные и их применение
JP2007521287A5 (enExample)
RU2007146462A (ru) Диарилгидантоины
AU2004272437A1 (en) CRF antagonists and heterobicyclic compounds
JP2013056930A5 (enExample)
JP2005514398A5 (enExample)
JP2009523812A5 (enExample)
EP2464227A1 (en) Compounds and methods of use thereof
CN108884061A (zh) 1,2,4-三嗪-3-胺类衍生物、其制备方法及其在医药上的应用
JPH11171865A (ja) 縮合ヘテロ環化合物
IL269144B2 (en) Pyrrolotriazine derivatives as kinase inhibitors
JPH0641471B2 (ja) チエノトリアゾロジアゼピン化合物およびその医薬用途
AU2020298779A1 (en) Estrogen-related receptor alpha (ERRα) modulators
WO2008124524A2 (en) Aryl sulfonamide compounds as modulators of the cck2 receptor
JP2017119628A (ja) 置換アゾール化合物及び糖尿病治療薬
JP2021014406A (ja) バソプレシン受容体拮抗剤
JPWO2016021706A1 (ja) 縮合複素環化合物
CN113754649B (zh) 一类含二唑、三唑及吡唑结构单元的吲哚衍生物及其应用